Tumor-intrinsic chemosensitivity assessed by KELIM and prognosis by BRCA status in patients with advanced ovarian carcinomas.
Becker O, Durand A, Chevrier M, Collet L, Gladieff L, Joly F, Sauterey B, Pomel C, Costaz H, Pautier P, Guillemet C, de la Motte Rouge T, Sabatier R, Classe JM, Petit T, Leblanc E, Marchal F, Colombo PE, Barranger E, Savoye AM, Bosquet L, Ray-Coquard I, Carton M, Colomban O, You B, Rodrigues M.
Becker O, et al. Among authors: durand a.
Int J Gynecol Cancer. 2024 Oct 31:ijgc-2024-005815. doi: 10.1136/ijgc-2024-005815. Online ahead of print.
Int J Gynecol Cancer. 2024.
PMID: 39481880